Therapeutics for complex disorders
We are the first rapid prototyping therapeutics company
OUR MISSION
We develop new therapeutics for complex disorders with unprecedented efficiency by integrating AI systems biology computation with rapid in vivo screening and clinical validation of discovered targets.
Disrupting Drug Discovery
-
Real Biology from Real Data
Our discovery starts with patient data, using the unique RNA signature of the patient to build an in-silico network using systems biology and our proprietary foundation model of human health. No data? We developed a home collection kit for RNAseq.
-
Effective Treatments & Targets
We rapidly identify therapeutic mechanisms regardless of root cause of the disease and use our proprietary database to specify molecules to restore health. Patients can’t wait for decades of basic research.
-
Rapid Clinical Impact
We derisk discovered therapeutic mechanisms in real patients using the off-target effects of existing drugs, letting us clinically derisk the therapeutic impact of new biology incredibly quickly and efficiently. By prototyping, we can more quickly and inexpensively discover what truly works.
OUR IMPACT
2
Drug candidates entering clinical trials
1
New molecule for Rett syndrome and other disorders
4
New therapeutic mechanisms and targets for rare and non-rare complex disorders
20%
Improved patient stratification by drug response, validated across 7+ clinical trials
200x
Higher hit rate of in silico predictions compared to phenotypic screening
